Candid Health, an AI revenue cycle management platform for healthcare providers, has raised $120M in Series D funding, the company announced July 22. The round triples the company’s valuation from its February 2025 Series C round of $52M.
The platform uses artificial intelligence to automate medical billing, claims processing, and revenue cycle workflows, helping healthcare providers reduce administrative overhead and accelerate reimbursement. Candid Health serves a growing customer base of hospitals and physician practices struggling with revenue cycle inefficiencies.
The funding reflects investor confidence in AI-powered revenue cycle tools, a market segment that has attracted significant venture capital as health systems seek to cut administrative costs. The company plans to use the new capital to expand its product offerings and scale its go-to-market operations.
Candid Health’s rapid valuation growth comes as the broader healthcare AI market continues to see robust investment activity, particularly in tools that address operational and administrative pain points.
